Clinical Research

Clinical Trials Drug Efficacy Drug Development Drug Trials Efficacy Studies Psychedelic Research Randomized Controlled Trials Epidemiology Drug Studies Pharmacovigilance

FDA Approves Xocova as First U.S. Post-Exposure COVID-19 Prevention

The five-day oral regimen gives a new option to prevent infection after exposure as U.S. use of the 2025–2026 updated COVID vaccine remains low.

Semaglutide Patents Lapse in India and China as Safety Scrutiny Rises

FDA Approves Teclistamab–Daratumumab Combination for Relapsed Multiple Myeloma After One Prior Therapy

FDA Grants Priority Review to Otsuka’s ADHD Drug Centanafadine With July 24 Decision Date

AstraZeneca Withdraws Andexxa From U.S. Market After FDA Says Risks Outweigh Benefits

Smartwatch Alerts Halve Severe Tantrums in Mayo Clinic Randomized Trial

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

Single Psilocybin Dose Plus Mindfulness Eases Depression for Frontline Clinicians in Randomized Trial

NMC Clears 10,650 MBBS Seats and 41 New Colleges, Taking India’s Total to 137,600

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

App-Based Relaxation Nearly Doubles Rate of Disability Improvement for ED Migraine Patients

MHRA Reforms and AI Cut UK Clinical Trial Approval Times to 41 Days

Mayo Clinic Launches Platform_Orchestrate as a Single Front Door for Faster Clinical Development

FDA Authorizes Essilor’s Stellest Lens, First U.S. Spectacle Lens Shown to Slow Childhood Myopia

FDA Launches New Safety Review of Abortion Pill Mifepristone

FDA Opens Door to Reconsider Capricor’s Duchenne Cell Therapy Based on HOPE-3 Data

Green-Mediterranean Diet Tied to Slower Brain Aging Markers in 18-Month Trial

Ultra-Processed Diet Drives Weight Gain in 21 Days, Controlled Trial Finds

EMA Flags Very Rare Vision-Loss Risk for Ozempic and Wegovy

Subcutaneous EEG Implant Outperforms Self-Reporting in Long-Term Seizure Monitoring